{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:00:34Z","timestamp":1791918034331,"version":"4.3.4"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"NIH","award":["1F31CA174096-01A1"],"award-info":[{"award-number":["1F31CA174096-01A1"]}]},{"name":"NIH","award":["P30 AR057235"],"award-info":[{"award-number":["P30 AR057235"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\u2003<\/jats:title>\n                    <jats:p>Thrombospondin-1 (TSP1), an endogenous antiangiogenic, is a widely expressed secreted ligand with roles in migration, adhesion, and proliferation and is a target for new therapeutics. While TSP1 is present in the bone matrix and several TSP1 receptors play roles in bone biology, the role of TSP1 in bone remodeling has not been fully elucidated. Bone turnover is characterized by coordinated activity of bone-forming osteoblasts (OB) and bone-resorbing osteoclasts (OC). TSP1\u2212\/\u2212 mice had increased bone mass and increased cortical bone size and thickness compared to wild type (WT). However, despite increased size, TSP1\u2212\/\u2212 femurs showed less resistance to bending than expected, indicative of diminished bone quality and a bone material defect. Additionally, we found that TSP1 deficiency resulted in decreased OC activity in vivo and reduced OC differentiation. TSP1 was critical during early osteoclastogenesis, and TSP1 deficiency resulted in a substantial overexpression of inducible nitric oxide synthase (iNOS). Importantly, administration of a NOS inhibitor rescued the OC function defects of TSP1\u2212\/\u2212 mice in vivo. To investigate the role of bone-derived TSP1 in osteoclastogenesis, we found that WT pre-OCs had defective iNOS expression when cultured on TSP1\u2212\/\u2212 bone compared to WT bone, suggesting that TSP1 in bone plays a critical role in iNOS signaling during OC development. These data implicate a new role for TSP1 in bone homeostasis with roles in maintaining bone matrix integrity and regulating OC formation. It will be critical to monitor bone health of patients administered TSP1-pathway directed therapeutics in clinical use and under development. \u00a9 2014 American Society for Bone and Mineral Research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jbmr.2308","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:23:01Z","timestamp":1404692581000},"page":"106-115","source":"Crossref","is-referenced-by-count":60,"title":["Thrombospondin-1 Regulates Bone Homeostasis Through Effects on Bone Matrix Integrity and Nitric Oxide Signaling in Osteoclasts"],"prefix":"10.1093","volume":"30","author":[{"given":"Sarah R","family":"Amend","sequence":"first","affiliation":[{"name":"Division of OncologyDepartment of MedicineWashington University School of MedicineSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Uluckan","sequence":"additional","affiliation":[{"name":"Division of OncologyDepartment of MedicineWashington University School of MedicineSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Hurchla","sequence":"additional","affiliation":[{"name":"Division of OncologyDepartment of MedicineWashington University School of MedicineSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Leib","sequence":"additional","affiliation":[{"name":"Department of OrthopedicsWashington University School of MedicineSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Veis Novack","sequence":"additional","affiliation":[{"name":"Division of Bone and Mineral Research, Department of MedicineWashington University School of MedicineSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of OrthopedicsWashington University School of MedicineSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Frazier","sequence":"additional","affiliation":[{"name":"Department of BiochemistryWashington University School of MedicineSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine N","family":"Weilbaecher","sequence":"additional","affiliation":[{"name":"Division of OncologyDepartment of MedicineWashington University School of MedicineSt. LouisMOUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,7,7]]},"reference":[{"key":"2024020319205572000_jbmr2308-bib-0001","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"Baron","year":"1996"},{"key":"2024020319205572000_jbmr2308-bib-0002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1365.035","article-title":"Androulakis, II. Bone remodeling","volume":"1092","author":"Hadjidakis","year":"2006","journal-title":"Ann NY Acad Sci."},{"issue":"6","key":"2024020319205572000_jbmr2308-bib-0003","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer."},{"issue":"7","key":"2024020319205572000_jbmr2308-bib-0004","doi-asserted-by":"crossref","first-page":"662","DOI":"10.18632\/oncotarget.200","article-title":"Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors","volume":"1","author":"Taraboletti","year":"2010","journal-title":"Oncotarget."},{"issue":"27","key":"2024020319205572000_jbmr2308-bib-0005","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1073\/pnas.1305569110","article-title":"Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response","volume":"110","author":"Tseng","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"issue":"9","key":"2024020319205572000_jbmr2308-bib-0006","doi-asserted-by":"crossref","first-page":"e25773","DOI":"10.4161\/onci.25773","article-title":"Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPalpha variants","volume":"2","author":"Weiskopf","year":"2013","journal-title":"Oncoimmunology."},{"issue":"6","key":"2024020319205572000_jbmr2308-bib-0007","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4103\/0250-474X.110572","article-title":"Nitric oxide modulators: an emerging class of medicinal agents","volume":"74","author":"Deshpande","year":"2012","journal-title":"Indian J Pharm Sci."},{"issue":"7","key":"2024020319205572000_jbmr2308-bib-0008","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1158\/0008-5472.CAN-08-3358","article-title":"CD47 regulates bone mass and tumor metastasis to bone","volume":"69","author":"Uluckan","year":"2009","journal-title":"Cancer Res."},{"issue":"10","key":"2024020319205572000_jbmr2308-bib-0009","doi-asserted-by":"crossref","first-page":"e77701","DOI":"10.1371\/journal.pone.0077701","article-title":"Low-Bone-Mass Phenotype of Deficient Mice for the Cluster of Differentiation 36 (CD36)","volume":"8","author":"Kevorkova","year":"2013","journal-title":"PLoS One."},{"issue":"41","key":"2024020319205572000_jbmr2308-bib-0010","doi-asserted-by":"crossref","first-page":"29333","DOI":"10.1074\/jbc.M113.494591","article-title":"Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein alpha (SIRPalpha) signaling","volume":"288","author":"Koskinen","year":"2013","journal-title":"J Biol Chem."},{"issue":"5","key":"2024020319205572000_jbmr2308-bib-0011","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI200316924","article-title":"c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation","volume":"111","author":"Faccio","year":"2003","journal-title":"J Clin Invest."},{"issue":"4","key":"2024020319205572000_jbmr2308-bib-0012","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1172\/JCI8905","article-title":"Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts","volume":"105","author":"McHugh","year":"2000","journal-title":"J Clin Invest."},{"issue":"1","key":"2024020319205572000_jbmr2308-bib-0013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bone.2010.09.016","article-title":"Integrins and bone metastasis: integrating tumor cell and stromal cell interactions","volume":"48","author":"Schneider","year":"2011","journal-title":"Bone."},{"issue":"7","key":"2024020319205572000_jbmr2308-bib-0014","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","article-title":"Thrombospondin-1 is a major activator of TGF-beta1 in vivo","volume":"93","author":"Crawford","year":"1998","journal-title":"Cell."},{"issue":"6","key":"2024020319205572000_jbmr2308-bib-0015","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2353\/ajpath.2008.071094","article-title":"Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen","volume":"172","author":"Posey","year":"2008","journal-title":"Am J Pathol."},{"issue":"3","key":"2024020319205572000_jbmr2308-bib-0016","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/ATVBAHA.110.220624","article-title":"Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties","volume":"31","author":"Smadja","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"4","key":"2024020319205572000_jbmr2308-bib-0017","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jbmr.5650090408","article-title":"Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro","volume":"9","author":"Grzesik","year":"1994","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2024020319205572000_jbmr2308-bib-0018","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1023\/A:1003448106673","article-title":"Location and distribution of non-collagenous matrix proteins in musculoskeletal tissues of rat","volume":"30","author":"Kannus","year":"1998","journal-title":"Histochem J."},{"issue":"2","key":"2024020319205572000_jbmr2308-bib-0019","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.108.2.719","article-title":"Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix","volume":"108","author":"Robey","year":"1989","journal-title":"J Cell Biol."},{"issue":"3","key":"2024020319205572000_jbmr2308-bib-0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1432-1033.1989.tb14783.x","article-title":"Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. A model to study the different effects of thrombospondin in cell adhesion","volume":"181","author":"Clezardin","year":"1989","journal-title":"Eur J Biochem."},{"issue":"2","key":"2024020319205572000_jbmr2308-bib-0021","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jcp.20735","article-title":"Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization","volume":"209","author":"Ueno","year":"2006","journal-title":"J Cell Physiol."},{"issue":"3","key":"2024020319205572000_jbmr2308-bib-0022","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbrc.2012.05.020","article-title":"Thrombospondin-1 inhibits osteogenic differentiation of human mesenchymal stem cells through latent TGF-beta activation","volume":"422","author":"Bailey Dubose","year":"2012","journal-title":"Biochem Biophys Res Commun."},{"issue":"7","key":"2024020319205572000_jbmr2308-bib-0023","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0945-053X(00)00107-4","article-title":"The cell biology of thrombospondin-1","volume":"19","author":"Chen","year":"2000","journal-title":"Matrix Biol."},{"issue":"3","key":"2024020319205572000_jbmr2308-bib-0024","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrc2561","article-title":"Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies","volume":"9","author":"Isenberg","year":"2009","journal-title":"Nat Rev Cancer."},{"issue":"36","key":"2024020319205572000_jbmr2308-bib-0025","doi-asserted-by":"crossref","first-page":"26069","DOI":"10.1074\/jbc.M605040200","article-title":"CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1","volume":"281","author":"Isenberg","year":"2006","journal-title":"J Biol Chem."},{"issue":"37","key":"2024020319205572000_jbmr2308-bib-0026","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.0502977102","article-title":"Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner","volume":"102","author":"Isenberg","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"2024020319205572000_jbmr2308-bib-0027","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1006\/bbrc.1995.2230","article-title":"Thrombospondin promotes resorption by osteoclasts in vitro","volume":"213","author":"Carron","year":"1995","journal-title":"Biochem Biophys Res Commun."},{"issue":"16","key":"2024020319205572000_jbmr2308-bib-0028","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2009-03-211920","article-title":"Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease","volume":"114","author":"Kukreja","year":"2009","journal-title":"Blood."},{"issue":"3","key":"2024020319205572000_jbmr2308-bib-0029","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1006\/bbrc.2000.2574","article-title":"A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro","volume":"270","author":"Carron","year":"2000","journal-title":"Biochem Biophys Res Commun."},{"issue":"2","key":"2024020319205572000_jbmr2308-bib-0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbrc.2006.11.057","article-title":"Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47\/SIRPalpha-interaction","volume":"352","author":"Lundberg","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"issue":"5","key":"2024020319205572000_jbmr2308-bib-0031","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1172\/JCI1684","article-title":"Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia","volume":"101","author":"Lawler","year":"1998","journal-title":"J Clin Invest."},{"issue":"2","key":"2024020319205572000_jbmr2308-bib-0032","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1538-7836.2006.01723.x","article-title":"Function-blocking antithrombospondin-1 monoclonal antibodies","volume":"4","author":"Annis","year":"2006","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2024020319205572000_jbmr2308-bib-0033","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/0008-5472.CAN-11-2681","article-title":"Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment","volume":"72","author":"Heller","year":"2012","journal-title":"Cancer Res."},{"issue":"12","key":"2024020319205572000_jbmr2308-bib-0034","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1359\/jbmr.1999.14.12.2159","article-title":"Growing C57Bl\/6 mice increase whole bone mechanical properties by increasing geometric and material properties","volume":"14","author":"Brodt","year":"1999","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024020319205572000_jbmr2308-bib-0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1359\/JBMR.050909","article-title":"Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse","volume":"21","author":"Silva","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"6","key":"2024020319205572000_jbmr2308-bib-0036","doi-asserted-by":"crossref","first-page":"065108","DOI":"10.1063\/1.3147383","article-title":"The bone diagnostic instrument III: testing mouse femora","volume":"80","author":"Randall","year":"2009","journal-title":"Rev Sci Instrum."},{"issue":"10","key":"2024020319205572000_jbmr2308-bib-0037","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1172\/JCI38576","article-title":"The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling","volume":"122","author":"Su","year":"2012","journal-title":"J Clin Invest."},{"issue":"4","key":"2024020319205572000_jbmr2308-bib-0038","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1096\/fj.09-138420","article-title":"Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit","volume":"24","author":"Morgan","year":"2010","journal-title":"FASEB J."},{"issue":"12","key":"2024020319205572000_jbmr2308-bib-0039","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/jbmr.1701","article-title":"Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts","volume":"27","author":"Cremasco","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024020319205572000_jbmr2308-bib-0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1083\/jcb.200212082","article-title":"Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin","volume":"162","author":"Faccio","year":"2003","journal-title":"J Cell Biol."},{"issue":"3\u20134","key":"2024020319205572000_jbmr2308-bib-0041","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12079-009-0074-2","article-title":"The interaction of Thrombospondins with extracellular matrix proteins","volume":"3","author":"Tan","year":"2009","journal-title":"J Cell Commun Signal."},{"key":"2024020319205572000_jbmr2308-bib-0042","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Termine","year":"1996"},{"issue":"7","key":"2024020319205572000_jbmr2308-bib-0043","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/jbmr.5650100718","article-title":"Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta","volume":"10","author":"Fedarko","year":"1995","journal-title":"J Bone Miner Res."},{"issue":"23","key":"2024020319205572000_jbmr2308-bib-0044","doi-asserted-by":"crossref","first-page":"15809","DOI":"10.1074\/jbc.M513225200","article-title":"RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption","volume":"281","author":"Zheng","year":"2006","journal-title":"J Biol Chem."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2308","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2308","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/1\/106\/56569054\/jbmr2308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/1\/106\/56569054\/jbmr2308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:52:34Z","timestamp":1710327154000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/30\/1\/106-115\/7599340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,7,7]]},"published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2308","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,1,1]]},"published":{"date-parts":[[2014,7,7]]}}}